IMNM
Immunome Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.21
−0.44%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.61
- Revenue estimate
- $153.8K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.65
- EPS estimate
- -$0.51
- Revenue actual
- —
- Revenue estimate
- $166.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.0%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $34
- PT range
- $24 – $40
- Analysts
- 6
5 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.51 | -$0.65 | Miss -26.51% | — |
| May 12, 2026 | -$0.60 | -$0.48 | Beat 20.00% | — |
| Mar 3, 2026 | -$0.65 | -$0.75 | Miss -15.38% | — |
| Nov 6, 2025 | -$0.57 | -$0.65 | Miss -14.04% | — |
| Aug 6, 2025 | -$0.52 | -$0.50 | Beat 3.85% | $4.0M |
| Mar 19, 2025 | -$0.68 | -$0.84 | Miss -23.53% | $2.7M |
| Nov 9, 2023 | -$0.17 | -$0.36 | Miss -111.76% | $3.6M |
| May 5, 2023 | $0.59 | -$0.35 | Miss -159.32% | $2.4M |
| Mar 16, 2023 | $0.67 | -$0.64 | Miss -195.52% | — |
| Nov 14, 2022 | -$0.76 | -$0.75 | Beat 1.32% | — |
| Aug 5, 2022 | -$0.75 | -$0.74 | Beat 1.33% | — |
| May 12, 2022 | -$0.69 | -$0.96 | Miss -39.13% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026